DIMENSIONAL FUND ADVISORS LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 127 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$27,389,247
+2.9%
1,336,672
-0.2%
0.01%
+12.5%
Q2 2023$26,609,753
+22.1%
1,339,159
+5.2%
0.01%
+14.3%
Q1 2023$21,796,141
+98601.0%
1,272,494
+12.8%
0.01%0.0%
Q4 2022$22,083
-99.8%
1,128,361
+27.7%
0.01%
+40.0%
Q3 2022$14,099,000
+134.5%
883,569
+102.2%
0.01%
+150.0%
Q2 2022$6,012,000
-8.7%
436,995
+5.2%
0.00%0.0%
Q1 2022$6,586,000
-21.9%
415,265
+7.5%
0.00%
-33.3%
Q4 2021$8,438,000
-24.6%
386,439
+3.2%
0.00%
-25.0%
Q3 2021$11,193,000
-49.2%
374,456
-24.7%
0.00%
-42.9%
Q2 2021$22,024,000
+61.0%
497,310
+61.3%
0.01%
+40.0%
Q1 2021$13,677,000
-25.8%
308,290
-8.2%
0.01%
-28.6%
Q4 2020$18,429,000
+135.0%
336,006
-2.0%
0.01%
+133.3%
Q3 2020$7,841,000
+10.2%
343,012
+0.9%
0.00%0.0%
Q2 2020$7,115,000
+85.1%
339,908
+23.4%
0.00%
+50.0%
Q1 2020$3,843,000
-34.0%
275,486
+7.7%
0.00%0.0%
Q4 2019$5,825,000
+256.9%
255,908
+82.7%
0.00%
+100.0%
Q3 2019$1,632,000
+424.8%
140,058
+575.8%
0.00%
Q2 2019$311,000
+46.7%
20,724
+71.1%
0.00%
Q1 2019$212,000
+18.4%
12,1120.0%0.00%
Q4 2018$179,00012,1120.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders